Litcius/Paper detail

Transdermal delivery of mitochondrial-targeted hydrogen sulphide donor, AP39 protects against 6-hydroxydopamine-induced mitochondrial dysfunction

Mandeep Kaur Marwah, Bahareh Manhoosh, Hala Shokr, Mohamad Anas Al Tahan, Roderick Stewart, Mohammed Iqbal, Lorena Diaz Sanchez, Sewa Abdullah, Shakil Ahmad, Keqing Wang, Karan Rana, Lissette Sanchez-Aranguren

2023European Journal of Pharmaceutics and Biopharmaceutics12 citationsDOIOpen Access PDF

Topics & Concepts

TransdermalChemistryMitochondrionHydroxydopaminePharmacologyBioenergeticsMPTPReactive oxygen speciesMitochondrial ROSDrug deliveryNeurotoxinBiochemistryBiologyMedicineParkinson's diseasePathologyOrganic chemistryDiseaseSulfur Compounds in BiologyNeuroscience of respiration and sleepAlcohol Consumption and Health Effects
Transdermal delivery of mitochondrial-targeted hydrogen sulphide donor, AP39 protects against 6-hydroxydopamine-induced mitochondrial dysfunction | Litcius